Enterome
Financing Round
- Series D+
Round Led or Co-led By SymBiosis
Enterome is a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. Enterome’s pioneering approach to drug discovery is based on its world-leading ability to decode the interaction between the gut microbiome and the immune system.
View Website
Modality
- Biologic
Indications
- Gastroenterology
- Immunology & Inflammation
- Oncology
Development Status
- Phase 2